<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35739136</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Long-COVID in children and adolescents: a systematic review and meta-analyses.</ArticleTitle><Pagination><StartPage>9950</StartPage><MedlinePgn>9950</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">9950</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-022-13495-5</ELocationID><Abstract><AbstractText>The objective of this systematic review and meta-analyses is to estimate the prevalence of long-COVID in children and adolescents and to present the full spectrum of symptoms present after acute COVID-19. We have used PubMed and Embase to identify observational studies published before February 10th, 2022 that included a minimum of 30 patients with ages ranging from 0 to 18&#xa0;years that met the National Institute for Healthcare Excellence (NICE) definition of long-COVID, which consists of both ongoing (4 to 12&#xa0;weeks) and post-COVID-19 (&#x2265;&#x2009;12&#xa0;weeks) symptoms. Random-effects meta-analyses were performed using the MetaXL software to estimate the pooled prevalence with a 95% confidence interval (CI). Heterogeneity was assessed using I<sup>2</sup> statistics. The Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) reporting guideline was followed (registration PROSPERO CRD42021275408). The literature search yielded 8373 publications, of which 21 studies met the inclusion criteria, and a total of 80,071 children and adolescents were included.&#xa0;The prevalence of long-COVID was 25.24%, and the most prevalent clinical manifestations were mood symptoms (16.50%), fatigue (9.66%), and sleep disorders (8.42%). Children infected by SARS-CoV-2 had a higher risk of persistent dyspnea, anosmia/ageusia, and/or fever compared to controls. Limitations of the studies analyzed include lack of standardized definitions, recall, selection, misclassification, nonresponse and/or loss of follow-up, and a high level of heterogeneity.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lopez-Leon</LastName><ForeName>Sandra</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7504-3441</Identifier><AffiliationInfo><Affiliation>Quantitative Safety &amp; Epidemiology, Novartis Pharmaceuticals, East Hanover, NJ, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rutgers Center for Pharmacoepidemiology and Treatment Science, Rutgers University, New Brunswick, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wegman-Ostrosky</LastName><ForeName>Talia</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-3207-6697</Identifier><AffiliationInfo><Affiliation>Subdirecci&#xf3;n de Investigaci&#xf3;n b&#xe1;sica, Instituto Nacional de Cancerolog&#xed;a, Mexico, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ayuzo Del Valle</LastName><ForeName>Norma Cipatli</ForeName><Initials>NC</Initials><Identifier Source="ORCID">0000-0002-8110-3532</Identifier><AffiliationInfo><Affiliation>Departamento de Pediatr&#xed;a, Tecnologico de Monterrey, Monterrey, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Perelman</LastName><ForeName>Carol</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0111-1154</Identifier><AffiliationInfo><Affiliation>Universidad Nacional Aut&#xf3;noma de M&#xe9;xico (UNAM), SOMEDICyT, RedMPC, Mexico City, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sepulveda</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-1146-9552</Identifier><AffiliationInfo><Affiliation>Harvard T.H. Chan School of Public Health, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rebolledo</LastName><ForeName>Paulina A</ForeName><Initials>PA</Initials><Identifier Source="ORCID">0000-0002-9808-063X</Identifier><AffiliationInfo><Affiliation>Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuapio</LastName><ForeName>Angelica</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9451-1914</Identifier><AffiliationInfo><Affiliation>Department of Medicine Huddinge, Center for Infectious Medicine, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villapol</LastName><ForeName>Sonia</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-6174-4113</Identifier><AffiliationInfo><Affiliation>Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, 6670 Bertner Avenue, R10-117, Houston, TX, 77030, USA. svillapol@houstonmethodist.org.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience in Neurological Surgery, Weill Cornell Medical College, New York, USA. svillapol@houstonmethodist.org.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="Y">Ageusia</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors are solely responsible for all content, and funders played no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. S.L.L. is an employee of Novartis Pharmaceutical Company; the statements presented in the paper do not necessarily represent the position of the company. The remaining authors declare no competing interests.
</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>23</Day><Hour>23</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>6</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35739136</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pii">10.1038/s41598-022-13495-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91:157&#x2013;160. doi: 10.23750/abm.v91i1.9397.</Citation><ArticleIdList><ArticleId IdType="doi">10.23750/abm.v91i1.9397</ArticleId><ArticleId IdType="pmc">PMC7569573</ArticleId><ArticleId IdType="pubmed">32191675</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, et al. A living WHO guideline on drugs for covid-19. BMJ. 2020;370:m3379. doi: 10.1136/bmj.m3379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3379</ArticleId><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua PEY, et al. Epidemiological and clinical characteristics of non-severe and severe pediatric and adult COVID-19 patients across different geographical regions in the early phase of pandemic: A systematic review and meta-analysis of observational studies. J. Investig. Med. 2021;69:1287&#x2013;1296. doi: 10.1136/jim-2021-001858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jim-2021-001858</ArticleId><ArticleId IdType="pmc">PMC8485127</ArticleId><ArticleId IdType="pubmed">34135068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kundu A, et al. Clinical aspects and presumed etiology of multisystem inflammatory syndrome in children (MIS-C): A review. Clin. Epidemiol. Glob. Health. 2022;14:100966. doi: 10.1016/j.cegh.2022.100966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2022.100966</ArticleId><ArticleId IdType="pmc">PMC8810427</ArticleId><ArticleId IdType="pubmed">35132389</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J, et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, et al. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect. Dis. 2021 doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Clements W, Joseph T, Koukounaras J. UK NICE guidelines for EVAR: Cost implications for post-COVID Australian Public Health. Cardiovasc Intervent. Radiol. 2021;44:1286&#x2013;1288. doi: 10.1007/s00270-021-02832-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00270-021-02832-2</ArticleId><ArticleId IdType="pubmed">33884459</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood SA, et al. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Bialek S, et al. Coronavirus disease 2019 in Children&#x2014;United States, February 12-April 2, 2020. Morb. Mortal Wkly. Rep. 2020;69:422&#x2013;426. doi: 10.15585/mmwr.mm6914e4.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6914e4</ArticleId><ArticleId IdType="pmc">PMC7147903</ArticleId><ArticleId IdType="pubmed">32271728</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. Rev. Esp. Cardiol. (Engl. Ed.) 2021;74:790&#x2013;799. doi: 10.1016/j.rec.2021.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rec.2021.07.010</ArticleId><ArticleId IdType="pubmed">34446261</ArticleId></ArticleIdList></Reference><Reference><Citation>Barendregt JJ, Doi SA, Lee YY, Norman RE, Vos T. Meta-analysis of prevalence. J. Epidemiol. Community Health. 2013;67:974&#x2013;978. doi: 10.1136/jech-2013-203104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jech-2013-203104</ArticleId><ArticleId IdType="pubmed">23963506</ArticleId></ArticleIdList></Reference><Reference><Citation>DerSimonian R, Laird N. Meta-analysis in clinical trials revisited. Contemp. Clin. Trials. 2015;45:139&#x2013;145. doi: 10.1016/j.cct.2015.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cct.2015.09.002</ArticleId><ArticleId IdType="pmc">PMC4639420</ArticleId><ArticleId IdType="pubmed">26343745</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikkenborg Berg S, et al. Long COVID symptoms in SARS-CoV-2-positive adolescents and matched controls (LongCOVIDKidsDK): A national, cross-sectional study. Lancet Child Adolesc. Health. 2022 doi: 10.1016/S2352-4642(22)00004-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00004-9</ArticleId><ArticleId IdType="pmc">PMC8820960</ArticleId><ArticleId IdType="pubmed">35143771</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L, Holm M, Knudsen M, Ellermann-Eriksen S, Hagstroem S. Long COVID symptoms and duration in SARS-CoV-2 positive children&#x2014;A nationwide cohort study. Eur. J. Pediatr. 2022 doi: 10.1007/s00431-021-04345-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00431-021-04345-z</ArticleId><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Roge I, et al. Comparison of persistent symptoms after COVID-19 and other non-SARS-CoV-2 infections in children. Front. Pediatr. 2021;9:752385. doi: 10.3389/fped.2021.752385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.752385</ArticleId><ArticleId IdType="pmc">PMC8586002</ArticleId><ArticleId IdType="pubmed">34778143</ArticleId></ArticleIdList></Reference><Reference><Citation>Smane L, Roge I, Pucuka Z, Pavare J. Clinical features of pediatric post-acute COVID-19: A descriptive retrospective follow-up study. Ital. J. Pediatr. 2021;47:177. doi: 10.1186/s13052-021-01127-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-021-01127-z</ArticleId><ArticleId IdType="pmc">PMC8390049</ArticleId><ArticleId IdType="pubmed">34446085</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, et al. Long COVID in children and adolescents. World J. Pediatr. 2021;17:495&#x2013;499. doi: 10.1007/s12519-021-00457-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-021-00457-6</ArticleId><ArticleId IdType="pmc">PMC8414448</ArticleId><ArticleId IdType="pubmed">34478045</ArticleId></ArticleIdList></Reference><Reference><Citation>Blankenburg J, et al. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci. Rep. 2022;12:2246. doi: 10.1038/s41598-022-06166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D, et al. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110:2208&#x2013;2211. doi: 10.1111/apa.15870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15870</ArticleId><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Erol N, Alpinar A, Erol C, Sari E, Alkan K. Intriguing new faces of Covid-19: Persisting clinical symptoms and cardiac effects in children. Cardiol. Young. 2021 doi: 10.1017/S1047951121003693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951121003693</ArticleId><ArticleId IdType="pmc">PMC8438511</ArticleId><ArticleId IdType="pubmed">34407902</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink TT, et al. Persistent symptoms and decreased health-related quality of life after symptomatic pediatric COVID-19: A prospective study in a Latin American tertiary hospital. Clinics (Sao Paulo) 2021;76:e3511. doi: 10.6061/clinics/2021/e3511.</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e3511</ArticleId><ArticleId IdType="pmc">PMC8595593</ArticleId><ArticleId IdType="pubmed">34852145</ArticleId></ArticleIdList></Reference><Reference><Citation>Knoke LSA, Maier C, Eitner L, L&#xfc;cke T, Brinkmann F. Pulmonary function and long-term respiratory symptoms in children and adolescents after COVID-19. Front. Pediatr. 2022 doi: 10.3389/fped.2022.851008.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2022.851008</ArticleId><ArticleId IdType="pmc">PMC9081758</ArticleId><ArticleId IdType="pubmed">35547532</ArticleId></ArticleIdList></Reference><Reference><Citation>Matteudi T, et al. Clinical characteristics of paediatric COVID-19 patients followed for up to 13 months. Acta Paediatr. 2021;110:3331&#x2013;3333. doi: 10.1111/apa.16071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.16071</ArticleId><ArticleId IdType="pmc">PMC8444774</ArticleId><ArticleId IdType="pubmed">34403523</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller FNV, et al. Prevalence of persistent symptoms in children during the COVID-19 pandemic: Evidence from a household cohort study in England and Wales. MedRxiv. 2021 doi: 10.1101/2021.05.28.21257602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.28.21257602</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, et al. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708&#x2013;718. doi: 10.1016/S2352-4642(21)00198-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Osmanov IM, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: A prospective cohort study. Eur. Respir. J. 2022;59:2101341. doi: 10.1183/13993003.01341-2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01341-2021</ArticleId><ArticleId IdType="pmc">PMC8576804</ArticleId><ArticleId IdType="pubmed">34210789</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA. 2021 doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Roessler MTF, Batram M, Jacob J, Loser F, Weidinger O, Wende D, Vivirito A, Toepfner N, Seifert M, Nagel O, K&#xf6;nig C, Jucknewitz R, Armann JP, Berner R, Treskova-Schwarzbach M, Hertle D, Scholz S, Stern S, Ballesteros P, Ba&#xdf;ler S, Bertele B, Repschl&#xe4;ger U, Richter N, Riederer C, Sobik F, Schramm A, Schulte C, Wieler L, Walker J, Scheidt-Nave C, Schmitt J. Post COVID-19 in children, adolescents, and adults: Results of a matched cohort study including more than 150,000 individuals with COVID-19. MedRxiv. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9648706</ArticleId><ArticleId IdType="pubmed">36355754</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusetsky Y, et al. Smell status in children infected with SARS-CoV-2. Laryngoscope. 2021;131:E2475&#x2013;E2480. doi: 10.1002/lary.29403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.29403</ArticleId><ArticleId IdType="pmc">PMC8013292</ArticleId><ArticleId IdType="pubmed">33443298</ArticleId></ArticleIdList></Reference><Reference><Citation>Say D, et al. Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. Lancet Child Adolesc. Health. 2021;5:e22&#x2013;e23. doi: 10.1016/S2352-4642(21)00124-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00124-3</ArticleId><ArticleId IdType="pmc">PMC8057863</ArticleId><ArticleId IdType="pubmed">33891880</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): A national matched cohort study. Lancet Child Adolesc. Health. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sterky E, et al. Persistent symptoms in Swedish children after hospitalisation due to COVID-19. Acta Paediatr. 2021;110:2578&#x2013;2580. doi: 10.1111/apa.15999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.15999</ArticleId><ArticleId IdType="pmc">PMC8444740</ArticleId><ArticleId IdType="pubmed">34157167</ArticleId></ArticleIdList></Reference><Reference><Citation>Zavala M, Ireland G, Amin-Chowdhury Z, Ramsay ME, Ladhani SN. Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: Active, prospective, national surveillance. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab991</ArticleId><ArticleId IdType="pmc">PMC8767867</ArticleId><ArticleId IdType="pubmed">34849658</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, et al. Long COVID in children&#x2014;Authors' reply. Lancet Child Adolesc. Health. 2022;6:e3. doi: 10.1016/S2352-4642(21)00344-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00344-8</ArticleId><ArticleId IdType="pmc">PMC8673911</ArticleId><ArticleId IdType="pubmed">34921808</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravens-Sieberer U, et al. Mental health and psychological burden of children and adolescents during the first wave of the COVID-19 pandemic-results of the COPSY study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2021;64:1512&#x2013;1521. doi: 10.1007/s00103-021-03291-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00103-021-03291-3</ArticleId><ArticleId IdType="pmc">PMC7920639</ArticleId><ArticleId IdType="pubmed">33649901</ArticleId></ArticleIdList></Reference><Reference><Citation>Solmi M, et al. Physical and mental health impact of COVID-19 on children, adolescents, and their families: The Collaborative Outcomes study on Health and Functioning during infection times&#x2014;Children and Adolescents (COH-FIT-C&amp;A) J. Affect. Disord. 2022;299:367&#x2013;376. doi: 10.1016/j.jad.2021.09.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.09.090</ArticleId><ArticleId IdType="pmc">PMC8486586</ArticleId><ArticleId IdType="pubmed">34606810</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun. Rev. 2022;21:103071. doi: 10.1016/j.autrev.2022.103071.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2022.103071</ArticleId><ArticleId IdType="pmc">PMC8848724</ArticleId><ArticleId IdType="pubmed">35182777</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: The immune system feels the heat. Nat. Rev. Immunol. 2015;15:335&#x2013;349. doi: 10.1038/nri3843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3843</ArticleId><ArticleId IdType="pmc">PMC4786079</ArticleId><ArticleId IdType="pubmed">25976513</ArticleId></ArticleIdList></Reference><Reference><Citation>Atzeni F, et al. One year in review 2019: Fibromyalgia. Clin. Exp. Rheumatol. 2019;37(Suppl 116):3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">30747097</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E, Pozo-Rosich P. Headache during COVID-19: Lessons for all, implications for the International Classification of Headache Disorders. Headache. 2021;61:385&#x2013;386. doi: 10.1111/head.14059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14059</ArticleId><ArticleId IdType="pmc">PMC8013461</ArticleId><ArticleId IdType="pubmed">33522600</ArticleId></ArticleIdList></Reference><Reference><Citation>Barizien N, et al. Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 2021;11:14042. doi: 10.1038/s41598-021-93546-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93546-5</ArticleId><ArticleId IdType="pmc">PMC8263555</ArticleId><ArticleId IdType="pubmed">34234251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif K, et al. On chronic fatigue syndrome and nosological categories. Clin. Rheumatol. 2018;37:1161&#x2013;1170. doi: 10.1007/s10067-018-4009-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4009-2</ArticleId><ArticleId IdType="pubmed">29417255</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P, et al. Variation in the human immune system is largely driven by non-heritable influences. Cell. 2015;160:37&#x2013;47. doi: 10.1016/j.cell.2014.12.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.12.020</ArticleId><ArticleId IdType="pmc">PMC4302727</ArticleId><ArticleId IdType="pubmed">25594173</ArticleId></ArticleIdList></Reference><Reference><Citation>Seessle J, et al. Persistent symptoms in adult patients one year after COVID-19: A prospective cohort study. Clin. Infect. Dis. 2021 doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C, et al. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur. J. Intern. Med. 2021 doi: 10.1016/j.ejim.2021.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Finckh A, Tramer MR. Primer: Strengths and weaknesses of meta-analysis. Nat. Clin. Pract. Rheumatol. 2008;4:146&#x2013;152. doi: 10.1038/ncprheum0732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncprheum0732</ArticleId><ArticleId IdType="pubmed">18227829</ArticleId></ArticleIdList></Reference><Reference><Citation>Cumpston M, et al. Updated guidance for trusted systematic reviews: A new edition of the cochrane handbook for systematic reviews of interventions. Cochrane Database Syst. Rev. 2019;10:ED000142. doi: 10.1002/14651858.ED000142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/14651858.ED000142</ArticleId><ArticleId IdType="pmc">PMC10284251</ArticleId><ArticleId IdType="pubmed">31643080</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi PGY, Zayyad H, Wertheim O, Wiegler KB, Jabal KA, Dror AA, Nazzal S, Glikman D, Edelstein M. Association between vaccination status and reported incidence of post-acute COVID-19 symptoms in Israel: A cross-sectional study of patients tested between March 2020 and November 2021. MedRxiv. 2022 doi: 10.1101/2022.01.05.22268800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.05.22268800</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>